Literature DB >> 2951225

Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes.

G A Oswald, J S Yudkin.   

Abstract

We studied 397 patients admitted to hospital with acute myocardial infarction (AMI) to validate an admission level of haemoglobin A1c (HbA1c) diagnostic for previously unknown diabetes mellitus by assessing glucose tolerance after 3 months. In 38% of survivors clearly abnormal HbA1c level (greater than 7.8) was 100% sensitive and 99% specific for diabetes with fasting hyperglycaemia, although the sensitivity fell to 67% when three diabetic subjects without fasting hyperglycaemia were included. Admission hyperglycaemia (plasma glucose greater than or equal to 11 mmol/l) was present in 20% of patients with AMI, of whom only one in five had levels of HbA1c indicating prior diabetes. Glycosylated haemoglobin is a more sensitive and specific test for diabetes in patients with AMI than admission hyperglycaemia. Undiagnosed diabetes was found in 4.3% of subjects with AMI who contributed 9.6% of hospital mortality.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951225     DOI: 10.1111/j.1464-5491.1987.tb00833.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  11 in total

Review 1.  An overview of glycemic control in the coronary care unit with recommendations for clinical management.

Authors:  Mikhail Kosiborod; Prakash Deedwania
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

2.  Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction.

Authors:  G A Oswald; C C Smith; A P Delamothe; D J Betteridge; J S Yudkin
Journal:  Br Heart J       Date:  1988-06

3.  Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.

Authors:  R P Gray; J S Yudkin; D L Patterson
Journal:  Br Heart J       Date:  1993-03

4.  Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?

Authors:  R P Gray; J S Yudkin; D L Patterson
Journal:  Br Heart J       Date:  1993-12

5.  The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction.

Authors:  Mahmut Cakmak; Nazmiye Cakmak; Sebnem Cetemen; Halil Tanriverdi; Yavuz Enc; Onder Teskin; I Dogu Kilic
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

6.  The relationship of hospital admission and fatality from myocardial infarction to glycohaemoglobin levels.

Authors:  J S Yudkin; G A Oswald; P M McKeigue; R D Forrest; C A Jackson
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

7.  Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.

Authors:  Yaron Arbel; Margalit Zlotnik; Amir Halkin; Ofer Havakuk; Shlomo Berliner; Itzhak Herz; Itay Rabinovich; Gad Keren; Shmuel Bazan; Ariel Finkelstein; Shmuel Banai
Journal:  Clin Res Cardiol       Date:  2013-11-24       Impact factor: 5.460

8.  Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction.

Authors:  Onur Baydar; Alparslan Kilic
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-02-21

9.  Stress hyperglycaemia in hospitalised patients and their 3-year risk of diabetes: a Scottish retrospective cohort study.

Authors:  David A McAllister; Katherine A Hughes; Nazir Lone; Nicholas L Mills; Naveed Sattar; John McKnight; Sarah H Wild
Journal:  PLoS Med       Date:  2014-08-19       Impact factor: 11.069

10.  Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Wenjun Pan; Haining Lu; Baotao Lian; Pengda Liao; Liheng Guo; Minzhou Zhang
Journal:  Cardiovasc Diabetol       Date:  2019-12-11       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.